359 related articles for article (PubMed ID: 9355779)
1. Guidelines for the treatment of ulcerative colitis in remission.
Ardizzone S; Molteni P; Bollani S; Bianchi Porro G
Eur J Gastroenterol Hepatol; 1997 Sep; 9(9):836-41. PubMed ID: 9355779
[TBL] [Abstract][Full Text] [Related]
2. A practical guide to the management of distal ulcerative colitis.
Ardizzone S; Bianchi Porro G
Drugs; 1998 Apr; 55(4):519-42. PubMed ID: 9561342
[TBL] [Abstract][Full Text] [Related]
3. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
4. Standard treatment of ulcerative colitis.
Gionchetti P; Rizzello F; Habal F; Morselli C; Amadini C; Romagnoli R; Campieri M
Dig Dis; 2003; 21(2):157-67. PubMed ID: 14571113
[TBL] [Abstract][Full Text] [Related]
5. Clinical guidelines for the medical management of left-sided ulcerative colitis and ulcerative proctitis: summary statement.
Regueiro M; Loftus EV; Steinhart AH; Cohen RD;
Inflamm Bowel Dis; 2006 Oct; 12(10):972-8. PubMed ID: 17012968
[TBL] [Abstract][Full Text] [Related]
6. Is maintenance therapy always necessary for patients with ulcerative colitis in remission?
Ardizzone S; Petrillo M; Imbesi V; Cerutti R; Bollani S; Bianchi Porro G
Aliment Pharmacol Ther; 1999 Mar; 13(3):373-9. PubMed ID: 10102971
[TBL] [Abstract][Full Text] [Related]
7. [Management of ulcerative colitis].
Rammert Ch; Kullak-Ublick GA
Ther Umsch; 2003 Mar; 60(3):145-50. PubMed ID: 12693317
[TBL] [Abstract][Full Text] [Related]
8. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.
Marshall JK; Irvine EJ
Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961
[TBL] [Abstract][Full Text] [Related]
9. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
10. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis.
Andreoli A; Spinella S; Levenstein S; Prantera C
Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759
[TBL] [Abstract][Full Text] [Related]
11. Review article: maintenance of remission in ulcerative colitis.
Kamm MA
Aliment Pharmacol Ther; 2002 Jul; 16 Suppl 4():21-4. PubMed ID: 12047255
[TBL] [Abstract][Full Text] [Related]
12. Drug therapy of inflammatory bowel disease.
Sack DM; Peppercorn MA
Pharmacotherapy; 1983; 3(3):158-76. PubMed ID: 6136027
[TBL] [Abstract][Full Text] [Related]
13. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine.
Naganuma M; Iwao Y; Ogata H; Inoue N; Funakoshi S; Yamamoto S; Nakamura Y; Ishii H; Hibi T
Inflamm Bowel Dis; 2001 Aug; 7(3):221-5. PubMed ID: 11515848
[TBL] [Abstract][Full Text] [Related]
14. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Sutherland L; Roth D; Beck P; May G; Makiyama K
Cochrane Database Syst Rev; 2002; (4):CD000544. PubMed ID: 12519547
[TBL] [Abstract][Full Text] [Related]
15. [Conservative therapy of ulcerative colitis and Crohn disease].
Rasenack J; Kreisel W
Fortschr Med; 1991 Apr; 109(11):245-7. PubMed ID: 1855750
[TBL] [Abstract][Full Text] [Related]
16. [Topical therapy of ulcerative colitis].
Rogler G; Beglinger C; Mottet C; Seibold F; Gross V
Praxis (Bern 1994); 2011 Nov; 100(23):1413-24. PubMed ID: 22086380
[TBL] [Abstract][Full Text] [Related]
17. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis.
Sutherland LR; May GR; Shaffer EA
Ann Intern Med; 1993 Apr; 118(7):540-9. PubMed ID: 8095128
[TBL] [Abstract][Full Text] [Related]
18. Topical therapy is underused in patients with ulcerative colitis.
Seibold F; Fournier N; Beglinger C; Mottet C; Pittet V; Rogler G;
J Crohns Colitis; 2014 Jan; 8(1):56-63. PubMed ID: 23566922
[TBL] [Abstract][Full Text] [Related]
19. Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials.
Regueiro M; Loftus EV; Steinhart AH; Cohen RD
Inflamm Bowel Dis; 2006 Oct; 12(10):979-94. PubMed ID: 17012969
[TBL] [Abstract][Full Text] [Related]
20. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
Segars LW; Gales BJ
Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
